Top Section/Ad
Top Section/Ad
Most recent
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
Pair enjoyed strong execution and tight pricing as US high grade credit remained resilient in the face of a sell-off in equity markets
More articles/Ad
More articles/Ad
More articles
-
Loan is a €500m increase on the existing notes -
Investors preferring to look after existing portfolios rather than risk another loss on another IPO
-
Swedish pet supply conglomerate issues undiscounted shares to fund acquisitions
-
Scott Bardo is returning to the fold after 10 years with Berenberg
-
German pharmaceuticals platform breaks the ice for large cap listings in Europe this year
-
It could take years to develop a gene therapy to slow aging, but much less for big pharma to scoop up Genflow Biosciences
